Hogan Lovells advised March Biosciences on the deal. March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, closed a...
March Biosciences’ $28.4 Million Series A Financing Round
Perspective Therapeutics’ $69 Million Shares Offering and $20.8 Million Private Placement
Hogan Lovells advised Perspective Therapeutics on a series of strategic transactions. Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX) has completed a series of strategic transactions with Lantheus Holdings (NASDAQ:...